Your browser doesn't support javascript.
loading
LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma.
Yang, Chunxiu; Pang, Jingjing; Xu, Jian; Pan, He; Li, Yueying; Zhang, Huainian; Liu, Huan; Xiao, Shu-Yuan.
Affiliation
  • Yang C; Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Pang J; Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.
  • Xu J; Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Pan H; Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.
  • Li Y; Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Zhang H; Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.
  • Liu H; Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Xiao SY; Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.
Cancer Cell Int ; 21(1): 343, 2021 Jul 03.
Article in En | MEDLINE | ID: mdl-34217264
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Cell Int Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Cell Int Year: 2021 Type: Article Affiliation country: China